Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer

Journal of Clinical Oncology

Volumn 23, Issue 15, 2005, Pages 3488-3494

  Han, Ji Youn ^a   Cho, Kwan Ho ^a   Lee, Dae Ho ^a   Kim, Hyae Young ^a   Kim, Eun A ^a   Lee, Sung Young ^a   Lee, Jin Soo ^a  

^a National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; IRINOTECAN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; BONE MARROW SUPPRESSION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; INFECTION; LEUKOPENIA; LUNG SMALL CELL CANCER; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING; ADJUVANT THERAPY; CANCER STAGING; COMPARATIVE STUDY; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; RADIATION DOSE; RADIATION RESPONSE; REMISSION; RISK ASSESSMENT; SKULL IRRADIATION; SMALL CELL CARCINOMA; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CARCINOMA, SMALL CELL; CISPLATIN; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 20644454660     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.01.082     Document Type: Article

References (24)

1. Pignon JP, Arriagada R, Ihde DC, et al: A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327:1618-1624, 1992
2. Warde P, Payne D: Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890-895, 1992
3. Stupp R, Monnerat C, Turrisi AT III, et al: Small cell lung cancer: State of the art and future perspectives. Lung Cancer 45:105-117, 2004
4. Erridge SC, Murray N: Thoracic radiotherapy for limited-stage small cell lung cancer: Issues of timing, volumes, dose, and fractionation. Semin Oncol 30:26-37, 2003
5. Fried DB, Morris DE, Poole C: Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 22: 4837-4845, 2004
6. Kudoh S, Fujiwara Y, Takada Y, et al: Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer: West Japan Lung Cancer Group. J Clin Oncol 16:1068-1074, 1998
7. Noda K, Nishiwaki Y, Kawahara M, et al: Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346:85-91, 2002
8. Kelly K: Irinotecan in small-cell lung cancer: Current data. Clin Lung Cancer 2:S4-S8, 2001 (suppl 2)
9. Han JY, Lee DH, Lee SY, et al: A phase II study of dose-intensified weekly concomitant adminstration of cisplatin and irinotecan in chemo-naïve patients with extensive disease small cell lung cancer. Med Oncol (in press)
10. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment: WHO Offset Publication No. 48. Geneva, Switzerland, World Health Organization, 1979
11. Simon R: Optimal two-stage designs for phase II clinical trials. Controlled Clin Trials 10:1-10, 1989
12. Kaplan ES, Meier P: Non-parametric estimation from incomplete observation. J Am Stat Assoc 53:457-481, 1958
13. Hryniuk W, Bush H: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2:1281-1288, 1984
14. Albain KS, Crowley JJ, LeBlanc M, et al: Determinants of improved outcome in small-cell lung cancer: An analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol 8:1563-1574, 1990
15. Arriagada R, Kramar A, Le Chevalier T, et al: Competing events determining relapse-free survival in limited small-cell lung carcinoma. J Clin Oncol 10:447-451, 1992
16. Turrisi AT III, Kim K, Blum R, et al: Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265-271, 1999
17. Skarlos DV, Samantas E, Briassoulis E, et al: Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG). Ann Oncol 12:1231-1238, 2001
18. Takada M, Fukuoka M, Kawahara M, et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group study 9104. J Clin Oncol 20:3054-3060, 2002
19. Edelman MJ, Chansky K, Gaspar LE, et al: Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/ carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713. J Clin Oncol 22:127-132, 2004
20. Vines EF, Le Pechoux C, Arriagada R: Prophylactic cranial irradiation in small cell lung cancer. Semin Oncol 30:38-46, 2003
21. Auperin A, Arriagada R, Pignon JP, et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission: Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341:476-484, 1999
22. Komaki R Cox JD, Whitson W: Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation. Cancer Treat Resp 65:811-814, 1981
23. Arriagada R, Le Chevalier T, Borie F, et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 87:183-190, 1995
24. Hirsch FR, Paulson OB, Hansen HH, et al: Intracranial metastases in small cell carcinoma of the lung: Correlation of clinical and autopsy findings. Cancer 50:2433-2437, 1982